We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$436M
AUM Growth
+$6.82M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
65.68%
Holding
29
New
1
Increased
9
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$19.1M
2
IQV icon
IQVIA
IQV
+$16.2M
3
ISRG icon
Intuitive Surgical
ISRG
+$12M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$10.8M
5
OM icon
Outset Medical
OM
+$3.91M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$14.3M
2
HUM icon
Humana
HUM
+$10.3M
3
AXNX
Axonics, Inc. Common Stock
AXNX
+$10.1M
4
BPMC
Blueprint Medicines
BPMC
+$8.62M
5
TXG icon
10x Genomics
TXG
+$8.08M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYEL icon
26
Lyell Immunopharma
LYEL
$353M
$733K 0.17%
5,000
– –
BCYC
27
Bicycle Therapeutics
BCYC
$288M
$547K 0.13%
23,500
– –
OLK
28
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$486K 0.11%
40,000
– –
BPMC
29
DELISTED
Blueprint Medicines
BPMC
– –
-170,551
Closed -$8.62M
1
2

Similar funds

ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Eagle Health Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Eagle Health Investments held 29 positions worth $436M, up 1.6% from $429M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Eagle Health Investments's Q3 2022 filing shows 1 new, 9 increased, 9 reduced and 1 closed positions. Its largest new stake was Tandem Diabetes Care: 196,400 shares worth $9.4M. The largest sale was Seagen Inc. Common Stock, an estimated $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Eagle Health Investments's largest Q3 2022 buy was Tandem Diabetes Care: 196,400 shares worth $9.4M.
  • Eagle Health Investments added most to Illumina in Q3 2022, an estimated $19.1M increase.
  • Eagle Health Investments's biggest Q3 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $14.3M.
  • Eagle Health Investments fully exited Blueprint Medicines in Q3 2022, selling an estimated $8.62M.
  • Eagle Health Investments's ten largest holdings make up 66% of its $436M portfolio in Q3 2022.
  • Eagle Health Investments opened 1 new position and closed 1 in Q3 2022.
  • Eagle Health Investments's portfolio value rose 1.6% quarter-over-quarter to $436M.

Based on Eagle Health Investments's 13F filing for Q3 2022, filed 14 Nov 2022.